“…The sensitivity of [ 18 F]FDG PET/CT is 15% higher than echocardiography for cardiac devices (6% for prosthetic valves), and 58% lower for native valves ( Guenther et al, 2015 ; Dell’Aquila et al, 2016 ; Fagman et al, 2016 ; Granados et al, 2016 ; Memmott et al, 2016 ; Salomäki et al, 2017 ; Sánchez-Enrique et al, 2018 ; Calais et al, 2019 ; de Camargo et al, 2019 ; Abikhzer et al, 2020 ; Gomes et al, 2020 ; Wang et al, 2020 ). Besides the poor detection accuracy in NVE, this imaging modality has possible false-negatives in patients with small biofilms, possible false-positives concerning early post-surgical prosthetic valve implantation ( Rosenbaum et al, 2006 ) or when active thrombi, cardiac tumors, and atrial fibrillation are present, a complex preparation protocol, and limited availability in peripheral centers ( Marchetta et al, 2017 ). Current guidelines stipulate that [ 18 F]FDG PET/CT should only be considered for IE diagnosis when > 3 months have elapsed after valve implantation to prevent false positives from artefacts following surgery ( Habib et al, 2015 ).…”